Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP);Cribado de cáncer de pulmón: Catorce años de experiencia del Programa Internacional de Detección Precoz de Cáncer de Pulmón con TBDR de Pamplona (P-IELCAP)

Archivos de Bronconeumologia

Volumn 51, Issue 4, 2015, Pages 169-176

  Sanchez Salcedo, Pablo ^a   Berto, Juan ^a   de Torres, Juan P ^a   Campo, Arantzazu ^a   Alcaide, Ana B ^a   Bastarrika, Gorka ^a   Pueyo, Jesús C ^a   Villanueva, Alberto ^a   Echeveste, José I ^a   Lozano, Maria D ^a   García Velloso, María J ^a   Seijo, Luis M ^b   García, Javier ^a   Torre, Wenceslao ^a   Pajares, Maria J ^c   Pío, Ruben ^c   Montuenga, Luis M ^c   Zulueta, Javier J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

LDCT; Lung cancer screening

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; EMPHYSEMA; EXPERIENCE; FEASIBILITY STUDY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SMOKING; SPAIN; SPIROMETRY; SURVIVAL RATE; ADENOCARCINOMA; ADVERSE EFFECTS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DIAGNOSIS; INCIDENCE; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; PROCEDURES; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RADIOGRAPHY; RISK; MEDICAL HISTORY; NON SMALL CELL LUNG CANCER; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK; SMOKING; SPAIN; SPIROMETRY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84933179881     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2015.02.015     Document Type: Article

References (40)

1. Henschke C.I., McCauley D.I., Yankelevitz D.F., Naidich D.P., McGuinness G., Miettinen O.S., et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 1999, 354:99-105.
2. Diederich S., Wormanns D., Semik M., Thomas M., Lenzen H., Roos N., et al. Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers. Radiology 2002, 222:773-781.
3. Sone S., Li F., Yang Z.G., Honda T., Maruyama Y., Takashima S., et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84:25-32.
4. Sobue T., Moriyama N., Kaneko M., Kusumoto M., Kobayashi T., Tsuchiya R., et al. Screening for lung cancer with low-dose helical computed tomography: Anti-lung cancer association project. J Clin Oncol 2002, 20:911-920.
5. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., Smith J.P., Miettinen O.S. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355:1763-1771.
6. Aberle D., Adams A., Berg C., Black W., Clapp J., Fagerstrom R., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
7. Humphrey L.L., Deffebach M., Pappas M., Baumann C., Artis K., Mitchell J.P., et al. Screening for lung cancer with low-dose computed tomography: A systematic review to update the U.S. Preventive Services Task Force Recommendation. Ann Int Med 2013, 159:411-420.
8. Becker N., Motsch E., Gross M.-L., Eigentopf A., Heussel C.P., Dienemann H., et al. Randomized study on early detection of lung cancer with MSCT in Germany: Study design and results of the first screening round. J Cancer Res Clin Oncol 2012, 138:1475-1486.
9. Van Iersel C.A., de Koning H.J., Draisma G., Mali W.P.T.M., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120:868-874.
10. Blanchon T., Bréchot J.-M., Grenier P.A., Ferretti G.R., Lemarié E., Milleron B., et al. Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007, 58:50-58.
11. Pedersen J.H., Ashraf H., Dirksen A., Bach K., Hansen H., Toennesen P., et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009, 4:608-614.
12. Infante M., Lutman F.R., Cavuto S., Brambilla G., Chiesa G., Passera E., et al. Lung cancer screening with spiral CT: Baseline results of the randomized DANTE trial. Lung Cancer 2008, 59:355-363.
13. Lopes Pegna A., Picozzi G., Mascalchi M., Maria Carozzi F., Carrozzi L., Comin C., et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009, 64:34-40.
14. De Torres J.P., Bastarrika G., Wisnivesky J.P., Alcaide A.B., Campo A., Seijo L.M., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007, 132:1932-1938.
15. Bastarrika G., García-Velloso M.J., Lozano M.D., Montes U., Torre W., Spiteri N., et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005, 171:1378-1383.
16. International Early Lung Cancer Action Program protocol [consultado 17 Oct 2013]. Disponible en: . http://www.ielcap.org/.
17. Vestbo J., Hurd S.S., Agustí A.G., Jones P.W., Vogelmeier C., Anzueto A., et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
18. Young R.P., Hopkins R.J., Targeted C.T. Image screening and its effect on lung cancer detection rate. Chest 2013, 144:1419-1420.
19. Church T.R., Black W.C., Aberle D.R., Berg C.D., Clingan K.L., Duan F., et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013, 368:1980-1991.
20. Lopes Pegna A., Picozzi G., Falaschi F., Carrozzi L., Falchini M., Carozzi F.M., et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol 2013, 8:866-875.
21. Saghir Z., Dirksen A., Ashraf H., Bach K.S., Brodersen J., Clementsen P.F., et al. The randomised Danish Lung Cancer Screening Trial: Status after five annual screening rounds with low-dose CT. Thorax 2012, 67:296-301.
22. Infante M., Cavuto S., Lutman F.R., Brambilla G., Chiesa G., Ceresoli G., et al. A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J Respir Crit Care Med 2009, 180:445-453.
23. Horeweg N., van der Aalst C.M., Vliegenthart R., Zhao Y., Xie X., Scholten E.T., et al. Volumetric computed tomography screening for lung cancer: Three rounds of the NELSON trial. Eur Respir J 2013, 42:1659-1667.
24. Ruano-Ravina A., Pérez Ríos M., Fernández-Villar A. Lung cancer screening with low-dose computed tomography after the National Lung Screening Trial. The debate is still open. Arch Bronconeumol 2013, 49:158-165.
25. Gohagan J.K., Marcus P.M., Fagerstrom R.M., Pinsky P.F., Kramer B.S., Prorok P.C., et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005, 47:9-15.
26. Wilson D.O., Weissfeld J.L., Fuhrman C.R., Fisher S.N., Balogh P., Landreneau R.J., et al. The Pittsburgh Lung Screening Study (PLuSS): Outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008, 178:956-961.
27. Swensen S.J., Jett J.R., Sloan J.A., Midthun D.E., Hartman T.E., Sykes A., et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002, 165:508-513.
28. Aberle D.R., DeMello S., Berg C.D., Black W.C., Brewer B., Church T.R., et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013, 369:920-931.
29. Pyenson B.S., Sander M.S., Jiang Y., Kahn H., Mulshine J.L. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) 2012, 31:770-779.
30. Detterbeck F.C., Mazzone P.J., Naidich D.P., Bach P.B. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e78S-e92S.
31. Shlomi D., Ben-Avi R., Balmor G.R., Onn A., Peled N. Screening for lung cancer: Time for large-scale screening by chest computed tomography. Eur Respir J 2014, 44:217-238.
32. Wilson D.O., Weissfeld J.L., Balkan A., Schragin J.G., Fuhrman C.R., Fisher S.N., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008, 178:738-744.
33. Kovalchik S.A., Tammemagi M., Berg C.D., Caporaso N.E., Riley T.L., Korch M., et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013, 369:245-254.
34. de Torres J.P., Marín J.M., Casanova C., Cote C., Carrizo S., Cordoba-Lanus E., et al. Lung cancer in patients with chronic obstructive pulmonary disease - incidence and predicting factors. Am J Respir Crit Care Med 2011, 184:913-919.
35. de-Torres J.P., Casanova C., Marín J.M., Zagaceta J., Alcaide A.B., Seijo L.M., et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study. Respir Med 2013, 107:702-707.
36. Maldonado F., Bartholmai B.J., Swensen S.J., Midthun D.E., Decker P.A., Jett J.R. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010, 138:1295-1302.
37. Young R.P., Hopkins R.J., Christmas T., Black P.N., Metcalf P., Gamble G.D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009, 34:380-386.
38. Powell H.A., Iyen-Omofoman B., Baldwin D.R., Hubbard R.B., Tata L.J. Chronic obstructive pulmonary disease and risk of lung cancer: The importance of smoking and timing of diagnosis. J Thorac Oncol 2013, 8:6-11.
39. Montes U., Seijo L.M., Campo A., Alcaide A.B., Bastarrika G., Zulueta J.J. Factors determining early adherence to a lung cancer screening protocol. Eur Respir J 2007, 30:532-537.
40. Dominioni L., Poli A., Mantovani W., Rotolo N., Imperatori A. Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer. Eur J Epidemiol 2011, 26:79-80.